How Ozempic, Wegovy, and Mounjaro compare on weight loss effectivenessByGrete SuarezPublishedNovember 10, 2023
Weight-loss drugs Ozempic and Saxenda are under investigation in the EU over suicide riskByAnanya BhattacharyaPublishedJuly 11, 2023
Surprising discoveries for the week of May 22: Betelgeuse, Chonkasaurus, DavidByMorgan HaefnerPublishedMay 26, 2023
Sunday Reads: BP shareholders revolt, Starship’s dust settles, swan factsByJulia MalleckPublishedApril 30, 2023
Surprising discoveries for the week of April 24: New ocean species, old candy, destroyed beerBySusan HowsonPublishedApril 28, 2023
Surprising discoveries from the week of April 10: Pooh, Mario, and MartinBySusan HowsonPublishedApril 17, 2023
Surprising discoveries from the week of April 3: Disco suits, tiger traits, and golf snacksBySusan HowsonPublishedApril 10, 2023
The US may make anti-overdose drug naloxone available over the counter in 2024ByAnnalisa MerelliPublishedDecember 27, 2022
How AbbVie denied Americans access to fair competition for HumiraByAnnalisa MerelliPublishedDecember 14, 2022
Quartz Weekend Brief—Market madness, Ethiopian land grabs, Mumbai’s wealthy, ocean soundscapesByQuartz StaffPublishedOctober 17, 2014
